Chad Grueter 140x200
Chad Grueter, PhD
Vice Chair for Research

The Department of Medicine has a long tradition of conducting rigorous and groundbreaking biomedical and clinical research. We foster a departmental culture that prizes scientific pursuit and a deep commitment to nurturing physician scientists. Nearly half our faculty engages in research in a wide variety of areas that includes diabetes, lymphoma, inflammation, viral pathogenesis, bio-defense, epithelial biology, gene therapy, vascular and myocardial biology, antibiotic resistance, clinical trials, and health services research. We invite you to explore these pages to learn more about the exciting discoveries continually being made in Internal Medicine.

Recent Publications

Explore this robust database provided by Iowa Research Online (ORI)

Research Resources

Department contacts, website design, and department and University resources.

Research Day

Our annual research event with internal and external presenters and a poster session!

Internal Medicine Affiliated Training Grants

The following training grants are currently active in the Department of Internal Medicine at the University of Iowa:

Training Grants

Program in Hematology: Molecular and Cell Biology Blood Cells

Program Director: Steven Lentz, MD, PhD

Project Number: T32 HL007344

Title: Program in Hematology: Molecular & Cell Biology of Blood Cells

Center Goals: This training program has as its primary objective to prepare young scientific investigators for productive careers in academic hematology. There is a particular need to expand the number of scientists and physician-scientists trained in research in the field of hematology because of its direct relevance to some of the most common human medical conditions, including abnormalities of immune cells, vascular diseases, disorders of blood clotting, and cancers of blood cells.

About the Fellowship: The program has as its primary objective to prepare MD, MD/PhD, and PhD postdoctoral fellows for productive careers as academic scientists and physician-scientists. The focus of training supported by this grant remains within the scientific discipline of hematology. An evolving feature of the training program is an expanded emphasis to provide training opportunities in translational research. The training will be carried out in an enriched environment of active basic and clinical investigation at an institution that emphasizes the career development and collaborative science.

The specific objectives are:

  1. To identify and recruit outstanding postdoctoral trainees, inclusive of gender, ethnicity and culture, who wish to obtain comprehensive knowledge of the principles and techniques of basic and translational research related to hematology, blood cells, vascular biology, coagulation, or hematological malignancies;
  2. To attract highly motivated scientists and physician-scientists and provide them with comprehensive instruction in the design and implementation of high quality research projects, including participation in cross-disciplinary research teams;
  3. To train physician-scientists for academic careers in hematology and related scientific disciplines and prepare them for successful transition to independent investigators; and
  4. To expose talented PhD scientists to the field of hematology and train them for careers as independent investigators.

Since the last renewal, the training program has undergone a transition to an expanded leadership team and several new initiatives have been instituted. These include the establishment of mentoring committees and individualized development plans for all trainees, an expanded emphasis to provide didactic and mentored training opportunities in translational science, and the implementation of several new strategies to improve diversity among trainees. The rich training environment provided by the diverse faculty, extensive laboratory, clinical, and core facilities, and strong institutional support should ensure continued success in attracting and preparing highly qualified postdoctoral trainees for careers in academic hematology.

For more information contact Dr. Steven Lentz

Research Training in Infectious Diseases

Program Director: Jack Stapleton, MD

Project Number: T32 AI007343

Title: Research Training In Infectious Diseases 

Center Goals: Human suffering due to infectious diseases is widespread, both due to the constant endemic diseases and emerging infectious diseases that can reach epidemic proportions. This program is designed to train biomedical and physician biomedical scientists in the most recent advances in basic and epidemiological sciences, in order to prepare them for productive career in all aspects of Infectious Diseases research.

About the Fellowship: The program, whose research emphasis is on the interface between human host and microbial (bacterial and viral) pathogens, provides an intense mentored research experience for MD and PhD postdoctoral trainees in infectious diseases. This occurs in conjunction with an individualized curriculum of didactic courses, seminars and journal clubs designed to encourage substantive interactions between MDs and PhDs. A short- term 3-month research experience for medical students is also offered. Most faculty are drawn from 1 basic science and 2 clinical departments, as well as 2 interdisciplinary PhD programs. Collaboration among program faculty is high. Research facilities are superb.

The scientific program centers around three major areas:

  1. Host Defense, emphasizing innate immunity;
  2. Bacterial Pathogenesis; and
  3. Viral Pathogenesis.

Faculty are divided into: 1) full members; and 2) associate members; on the basis of their extramural research support and their experience both as an independent investigator and research mentor. Primary research mentors come from faculty meeting the criteria for full membership. An important aspect of the 3-year research experience for MD postdoctoral trainees with minimal prior research experience is an intensive exposure to a broad spectrum of graduate level basic science courses. All postdoctoral trainees establish a Research Advisory Committee. All trainees attend a research conference, as well as a seminar/ journal club designed to encourage cross-fertilization of ideas and scientific approaches between clinical medicine and basic science. They will interact with outstanding visiting scientists, attend scientific meetings, learn scientific writing and grant preparation skills, and complete a course in research and biomedical ethics. A recruitment program for minority trainees is in place and is being further expanded. In summary, this proposal requests continuation of an ongoing training program with an excellent training record which will provide a coordinated and integrated training experience for postdoctoral MD and PhD trainees in infectious diseases research related to the microbial pathogenesis of bacterial and viral infections of humans

For more information contact: Dr. Jack Stapleton or Dr. Lee-Ann H. Allen.

Training in Mechanisms of Parasitism

Program Director: Mary Wilson, MD

Project Number: T32 AI007511

Title: Training in Mechanisms of Parasitism

Principal Investigators: Mary E. Wilson, MD, and Patrick M. Schlievert, PhD

For additional information, see this page.

Goals of the Training Plan: This proposal is based upon the hypothesis that the mechanisms through which pathogenic microbes invade and elicit disease in mammalian hosts, and responses of the host to these microbial pathogens, will share common features between microbes from different phyla, i.e., protozoa, helminths, bacteria, and viruses. A corollary is that the same technology can be applied to investigations of microbial virulence/host responses to different pathogens. As such, an integrated approach to these host-parasite interactions will enhance progress in each individual field. Our experience through this training program has shown that not only is it beneficial to foster these interactions at the level of the principal investigator, but that interactions promoted at the trainee level also “trickle up” for the benefit of the mentors.

According to the above hypotheses and observations, the goals of the program are: (1) to foster collaborations among scientists and trainees with expertise in complementary disciplines; (2) to encourage trainees to take advantage of the expertise of faculty members in diverse fields; (3) to ensure that trainees are well informed of new advances in technology and their applications to biological questions; (4) to foster interactions among graduate students, PhD postdoctoral fellows, and MD fellows in different laboratories; and (5) to carefully monitor the progress of trainees so that their learning and productivity are maximized.

About the Fellowship:

  • Funded since 1996.
  • Currently supporting three predoctoral students (combined M.D./Ph.D. or Ph.D. only) and four postdoctoral fellows.
  • Trainees participate in:
    • Seminars
    • Journal clubs
    • Annual retreat
    • Career development
    • Grant-writing
    • Graduate courses
    • Bench research
  • Major contributing departments and programs:
    • Microbiology and Immunology
    • Internal Medicine
    • Pediatrics
    • Epidemiology
    • Biomedical Engineering
    • Inflammation Program
  • Applications are requested in April of each year and new trainees are appointed on August 1. 

For more information about the grant and information on how to apply contact: Angie Robertson (angie-robertson@uiowa.edu).

*Eligibility

Support provided for predoctoral students (PhD or MD/PhD) and postdoctoral scholars. Trainee appointments must meet the eligibility requirements set by the funding organization, be mentored by a faculty member/preceptor participating in the training program, and be chosen through the individual training program’s selection process.

Research News

Four Internal Medicine faculty honored during 2025 Celebration of Excellence
Tuesday, April 29, 2025
In recognition of its tradition of exemplary scholarly activity, the Roy J. and Lucille A. Carver College of Medicine (CCOM) held its annual Celebration of Excellence in Research, Scholarship, Teaching, and Service on Monday, adding faculty with appointments in the Department of Internal Medicine to its Wall of Scholarship, naming Impact Scholars, and presenting Faculty Awards.
Boudreau combines heart disease research projects under new NIH R35
Wednesday, April 23, 2025
Ryan Boudreau, PhD, associate professor in cardiovascular medicine has received a seven-year, $7.6M R35 NHLBI Emerging Investigator Award (EIA) to support a comprehensive research program examining the genetic and molecular mechanisms underlying heart disease, the global leading cause of death.
Welsh receives Canada Gairdner International Award for cystic fibrosis discoveries
Friday, April 11, 2025
Michael Welsh, MD, University of Iowa professor of internal medicine, has received the 2025 Canada Gairdner International Award for his research on cystic fibrosis (CF), which paved the way to new therapies that have transformed the health and life expectancy of people with CF.
Curiosity and collaboration, leading to excellence
Friday, April 11, 2025
Michael Welsh’s research changed understanding and treatment of cystic fibrosis. His drive to learn and forward-looking approach exemplifies teamwork and shared success at Iowa.
Cancer Research Building will pave way for significant discoveries at UI
Thursday, April 10, 2025
As the university advances plans for a new, state-of-the-art Cancer Research Building, leaders say the facility will pave the way for significant discoveries to be made at the University of Iowa.
Respiratory flare ups may signal COPD in smokers with normal lung function
Friday, February 28, 2025
A study led by Spyridon Fortis, MD, PhD, MS, was published recently in the American Journal of Respiratory and Critical Care Medicine.
London invited to join NHLBI Mentored Clinical and Basic Science Study Section
Monday, February 17, 2025
Barry London, MD, PhD, Division Director of Cardiovascular Medicine, has been invited to join the National Institutes of Health’s National Heart, Lung, and Blood Institute’s Mentored Clinical and Basic Science Study Section (MCBS).
Farooq and Zembrzuska collaborate in cellular therapy work
Thursday, January 23, 2025
Hanna Zembrzuska, MD, MME and Umar Farooq, MD have joined forces to understand how chimeric antigen receptor T cell (CAR-T cell) research might be applied to develop new treatments for a range of conditions, such as autoimmune diseases.
O’Neill appointed to prestigious American Society for Clinical Investigation
Friday, January 17, 2025
Brian O’Neill, MD, PhD, has been named a member of the American Society for Clinical Investigation (ASCI), one of the most distinguished organizations for physician-scientists.
Shining a light on racial disparities in neuroendocrine tumor research
Friday, December 20, 2024
Hematology-oncology fellow Udhayvir Singh Grewal, MD presented at the North American Neuroendocrine Tumor Society (NANETS) conference recently in Chicago.

Investigators and Research Groups

Visit laboratory websites in the following specialty categories:


 

New Funding Awards

October 2024
New Federal Awards
Kale BongersNIH K08
5 years
The Role of the Gut Microbiome in Post-Sepsis Skeletal Muscle Atrophy
Other Awards
Alejandro Comellas FreymondNational Jewish HealthGenetic Epidemiology of COPD (COPD Gene)
Douglas LauxAscendis Pharma A/STransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 /, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Sneha PhadkeBoehringer Ingelheim Pharma GmbH & Co.Beamion BCGC-1: A Phase Ib dose escalation and Phase II dose optimization, randomized, open-label, multicenter trial of oral zongertinib (BI 1810631) in combination with intravenous trastuzumab deruxtecan (T-DXd) or in combination with intravenous trastu

Job Opportunities